Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M DeAngelo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Molecular, Biological, and Multi-Scale Communications|July 3, 2023
Drug Cocktail Formulation via Circuit DesignDouglas Raymond Beahm, Yijie Deng, Thomas M DeAngelo, et al.
IEEE Transactions on Computational Biology and Bioinformatics|August 14, 2025
Six Fundamental Behaviors of Immune-Pathogen Feedback CircuitsDouglas Raymond Beahm, Thomas M DeAngelo, Shouka Tavakolian, et al.
Nature Communications|September 29, 2025
Structural insights into chemoresistance mutants of BCL-2 and their targeting by stapled BAD BH3 helicesThomas M DeAngelo, Utsarga Adhikary, Kyle J Korshavn, et al.
Cell Reports. Medicine|November 27, 2025
A triple-action PROTAC for wild-type p53 cancer therapyGregory H Bird, Utsarga Adhikary, Michael J Schmidt, et al.
Cell|November 22, 2025
Inhibition of oligomeric BAX by an anti-apoptotic dimerCatherine E Newman, Micah A Gygi, Haleh Alimohamadi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Molecular, Biological, and Multi-Scale Communications|July 3, 2023
Drug Cocktail Formulation via Circuit DesignDouglas Raymond Beahm, Yijie Deng, Thomas M DeAngelo, et al.
IEEE Transactions on Computational Biology and Bioinformatics|August 14, 2025
Six Fundamental Behaviors of Immune-Pathogen Feedback CircuitsDouglas Raymond Beahm, Thomas M DeAngelo, Shouka Tavakolian, et al.
Nature Communications|September 29, 2025
Structural insights into chemoresistance mutants of BCL-2 and their targeting by stapled BAD BH3 helicesThomas M DeAngelo, Utsarga Adhikary, Kyle J Korshavn, et al.
Cell Reports. Medicine|November 27, 2025
A triple-action PROTAC for wild-type p53 cancer therapyGregory H Bird, Utsarga Adhikary, Michael J Schmidt, et al.
Cell|November 22, 2025
Inhibition of oligomeric BAX by an anti-apoptotic dimerCatherine E Newman, Micah A Gygi, Haleh Alimohamadi, et al.
Pageof 1